Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis


Goodin D. S. , Biermann L. D. , Bohlega S., Boiko A., Chofflon M., Gebeily S., ...Daha Fazla

CURRENT MEDICAL RESEARCH AND OPINION, cilt.23, ss.2823-2832, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 23 Konu: 11
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1185/03007x233007
  • Dergi Adı: CURRENT MEDICAL RESEARCH AND OPINION
  • Sayfa Sayıları: ss.2823-2832

Özet

Background: As results from an increasing number of clinical trials with disease-modifying drugs (DMDs) in multiple sclerosis (MS) become available, the challenge for the treating is how to decide on the appropriate therapy for an individual patient.